| Cellulite: a review ABR Rossi, AL Vergnanini Journal of the European Academy of Dermatology and Venereology 14 (4), 251-262, 2000 | 544 | 2000 |
| Ultraviolet radiation and the skin: Photobiology and sunscreen photoprotection AR Young, J Claveau, AB Rossi Journal of the American Academy of Dermatology 76 (3), S100-S109, 2017 | 364 | 2017 |
| Atopic dermatitis in the pediatric population: a cross-sectional, international epidemiologic study JI Silverberg, S Barbarot, A Gadkari, EL Simpson, S Weidinger, ... Annals of Allergy, Asthma & Immunology 126 (4), 417-428. e2, 2021 | 232 | 2021 |
| Influence of facial skin attributes on the perceived age of Caucasian women A Nkengne, C Bertin, GN Stamatas, A Giron, A Rossi, N Issachar, B Fertil Journal of the European Academy of Dermatology and Venereology 22 (8), 982-991, 2008 | 195 | 2008 |
| Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years C Paul, M Cork, AB Rossi, KA Papp, N Barbier, Y de Prost Pediatrics 117 (1), e118-e128, 2006 | 142 | 2006 |
| Laboratory safety of dupilumab in moderate‐to‐severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS) A Wollenberg, LA Beck, A Blauvelt, EL Simpson, Z Chen, Q Chen, ... British Journal of Dermatology 182 (5), 1120-1135, 2020 | 135 | 2020 |
| Cellulite MP Goldman, PA Bacci, G Leibaschoff, D Hexsel, F Angelini Taylor & Francis,, 2006 | 114 | 2006 |
| Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 … JI Silverberg, G Yosipovitch, EL Simpson, BS Kim, JJ Wu, L Eckert, ... Journal of the American Academy of Dermatology 82 (6), 1328-1336, 2020 | 106 | 2020 |
| Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis LA Beck, MJ Cork, M Amagai, A De Benedetto, K Kabashima, ... JID Innovations 2 (5), 100131, 2022 | 82 | 2022 |
| Clinically meaningful responses to dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: post-hoc analyses from a randomized clinical trial AS Paller, A Bansal, EL Simpson, M Boguniewicz, A Blauvelt, ... American Journal of Clinical Dermatology 21, 119-131, 2020 | 68 | 2020 |
| Nomenclature and clinical phenotypes of atopic dermatitis G Girolomoni, M de Bruin-Weller, V Aoki, K Kabashima, M Deleuran, ... Therapeutic advances in chronic disease 12, 20406223211002979, 2021 | 67 | 2021 |
| Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global … JI Silverberg, EL Simpson, M Ardeleanu, D Thaçi, S Barbarot, J Bagel, ... British Journal of Dermatology 181 (1), 80-87, 2019 | 54 | 2019 |
| Evaluation of the efficacy of a topical cosmetic slimming product combining tetrahydroxypropyl ethylenediamine, caffeine, carnitine, forskolin and retinol, In vitro, ex vivo and … R Roure, T Oddos, A Rossi, F Vial, C Bertin International journal of cosmetic science 33 (6), 519-526, 2011 | 54 | 2011 |
| Fragility of epidermis in newborns, children and adolescents U Blume‐Peytavi, J Tan, D Tennstedt, F Boralevi, G Fabbrocini, A Torrelo, ... Journal of the European Academy of Dermatology and Venereology 30, 3-56, 2016 | 51 | 2016 |
| An open-label, multicenter study of the combination of amorolfine nail lacquer and oral itraconazole compared with oral itraconazole alone in the treatment of severe toenail … M Lecha, M Alsina, JMT Rodriguez, FR de Erenchun, A Mirada, AB Rossi Current therapeutic research 63 (6), 366-379, 2002 | 44 | 2002 |
| Efficacy of dupilumab in different racial subgroups of adults with moderate-to-severe atopic dermatitis in three randomized, placebo-controlled phase 3 trials AF Alexis, M Rendon, JI Silverberg, DM Pariser, B Lockshin, CE Griffiths, ... Journal of drugs in dermatology: JDD 18 (8), 804-813, 2019 | 43 | 2019 |
| Dupilumab significantly improves skin barrier function in patients with moderate‐to‐severe atopic dermatitis E Berdyshev, E Goleva, R Bissonnette, I Bronova, AS Bronoff, BN Richers, ... Allergy 77 (11), 3388-3397, 2022 | 42 | 2022 |
| Control of atopic eczema with pimecrolimus cream 1% under daily practice conditions: results of a> 2000 patient study J Ring, A Abraham, C De Cuyper, K Kim, T Langeland, V Parra, P Pigatto, ... Journal of the European Academy of Dermatology and Venereology 22 (2), 195-203, 2008 | 42 | 2008 |
| Dupilumab improves asthma and sinonasal outcomes in adults with moderate to severe atopic dermatitis M Boguniewicz, LA Beck, L Sher, E Guttman-Yassky, D Thaçi, A Blauvelt, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (3), 1212-1223. e6, 2021 | 39 | 2021 |
| Efficacy of a global supportive skin care program with hydrotherapy after non metastatic breast cancer treatment: a randomised controlled study SV Dalenc F, Ribet V, Rossi AB, Guyonnaud J, Bernard-Marty C, de Lafontan B ... Eur J Cancer Care 27 (1), 2017 | 34* | 2017 |
Eric SimpsonFrances J. Storrs Medical Dermatology Professor, Dermatology, OHSUVerified email at ohsu.edu
